Showing results (41-50 of 106) with videos related to

Sort By:
Pageof 11
South Asian Journal of Cancer|December 31, 2025
Spectrum of Resistance Mechanisms to ALK TKIs in NSCLC: Largest Single-Center Experience from IndiaUllas Batra, Shrinidhi Nathany, Mansi Sharma, et al.
Indian Journal of Surgical Oncology|May 27, 2017
Prognostic Factors in Indian Patients Operated for Soft Tissue Sarcomas-a Retrospective Cross-sectional AnalysisAkshay Tiwari, Swati Shah, Ashwani Kumar Sharma, et al.
Indian Journal of Medical Microbiology|August 12, 2023
Impact of improving infection control and antibiotic stewardship practices on nosocomial infections and antimicrobial resistance in an oncology centre from IndiaNitin Bansal, Pankaj Goyal, Dharmishtha Basu, et al.
Cancer Medicine|September 7, 2022
KRAS mutated Non-Small Lung Carcinoma: A Real World Context from the Indian subcontinentUllas Batra, Shrinidhi Nathany, Mansi Sharma, et al.
Asia-Pacific Journal of Clinical Oncology|February 23, 2023
Clinical management of stage III non-small cell lung cancer in India: An expert consensus statementUllas Batra, Kumar Prabhash, Jai Prakash Agarwal, et al.
Journal of Robotic Surgery|October 10, 2025
Robotic versus open esophagectomy: a propensity score-matched analysis from a tertiary cancer center in IndiaAnupam Lahiri, Shaifali Goel, Abhishek Aggarwal, et al.
Journal of Carcinogenesis|August 21, 2013
Epidermal growth factor receptor mutation in lung adenocarcinoma in India: A single center studyDinesh Chandra Doval, Saud Azam, Ullas Batra, et al.
Indian Journal of Surgical Oncology|October 3, 2022
Analysis of Clinical Outcomes of Patients with Soft Tissue SarcomaLokesh Garg, Manish Pruthi, Ullas Batra, et al.
Immunotherapy|June 14, 2022
Immunotherapy in advanced non-small-cell lung cancer (NSCLC) after progression on chemotherapy: real-world results from a prospective institutional cohortUllas Batra, Kundan Singh Chufal, Shrinidhi Nathany, et al.
Lung India : Official Organ of Indian Chest Society|October 23, 2025
Circulating tumour DNA as a predictive biomarker for tumour response and prolonged clinical benefit with nivolumab in advanced non-small cell lung cancerUllas Batra, Mansi Sharma, Shrinidhi Nathany, et al.
Pageof 11